The optimal cut-off value of the AFP ratio in this study was 0.83, and HCC patients with AFP ratios less than 0.8 had significantly lower recurrence-free survival than those with AFP ratios greater than 0.8 in training and validation groups. This evidence concerns the gene AFP and hepatocellular carcinoma.